CareDx. which two weeks ago entered into an agreement to acquire ImmuMetrix Inc., has announced that it intends to make an initial public offering (IPO) of common stock with the intent of realizing $50 million. Brisbane, CA–based ...
Prometheus Laboratories, a developer of diagnostic products, has introduced new Prometheus Anser infliximab (IFX) monitoring test. By utilizing the company's proprietary homogenous mobility shift assay (HMSA), the test measures infliximab ...
Tags: Prometheus, IFX, monitoring test, HMSA, IBD